Schedule of acquisition of assets (Details) - USD ($) |
1 Months Ended | ||
|---|---|---|---|
Jan. 01, 2024 |
Dec. 28, 2023 |
Dec. 31, 2023 |
|
| Series F Preferred Stock [Member] | |||
| Asset Acquisition [Line Items] | |||
| Issuance of convertible preferred stock | 511,308 | 8,000,000 | |
| Odyssey Health Inc [Member] | |||
| Asset Acquisition [Line Items] | |||
| Total fair value of considerations | $ 10,273,506 | ||
| Cash | 1,000,000 | ||
| Assumed liabilities | 325,672 | ||
| Total fair value of considerations | $ 10,273,506 | ||
| Odyssey Health Inc [Member] | Series F Preferred Stock [Member] | |||
| Asset Acquisition [Line Items] | |||
| Issuance of convertible preferred stock | 8,000,000 | ||
| Equity - Preferred stock | $ 8,947,834 |
| X | ||||||||||
- Definition Asset acquisition consideration transferred liability incured. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|